IQVIA™ Real-World Insights Bibliography

Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Author(s): Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publication(s):  BMC Gastroenterology
BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Type(s): Article,
Countries: Australia, Canada, Italy, UK,
Click here for the abstract
C:
Y:
Oncology,
2020
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Treat and extend treatment interval patterns with anti-VEGF therapy in nAMD patients
Author(s): Skelly A1, Bezlyak V1, Liew G2, Kap E3, Sagkriotis A1
Affiliations(s): 1. Novartis Pharma AG, 4002 Basel, Switzerland; 2. Westmead Institute for Medical Research, University of Sydney, Westmead NSW 2145, Australia; 3. IQVIA Commercial GmbH & Co. OHG, 60549 Frankfurt, Germany
Publication(s): 
Document Type(s): Article,
Countries: Australia,
Click here for the abstract
C:
Y:
Ophthalmology,
2019
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC)
Author(s): Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6
Affiliations(s): 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy
Publication(s):  BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Type(s): Poster,
Countries: Australia, Canada, Italy, UK,
C:
Y:
Oncology,
2019
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Author(s):  Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations(s): IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Author(s):  Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations(s): 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Identifying the confuonders that explain the difference in readouts between non-interventional and randomized controlled trials: the case of treatments in neovascular age-related macular degeneration
Author(s): Sakriotis A1, Griner R2, Durus A1, Doyle OM2, Rodriguez-Torres L1, Wintermantel T2, Clemens A13
Affiliations(s): 1. Novartis Pharma AG, Basel, Switzerland; 2. IQVIA Real World Insights, Switzerland/UK/US; 3. Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany
Publication(s):  ISPOR Europe, Barcelona, Spain, 10-14 November 2018
Document Type(s): Poster,
Countries: Australia, UK, USA,
C:
Y:
Ophthalmology,
2018
  L:
A:
English
clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.
Author(s): Johnston RL1,2, Carius HJ3, Skelly A4, Ferreira A5, Milnes F4, Mitchell P6.
Affiliations(s): 1 The Royal College of Ophthalmologists' National Ophthalmology Database, London, UK. 2 Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK. 3 QuintilesIMS, Frankfurt am Main, Germany. 4 Novartis Pharma AG, Basel, Switzerland. 5 Novartis Pharma AG, Basel, Switzerland. alberto.ferreira@novartis.com. 6 Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Westmead, NSW, Australia.
Publication(s):  Advances in therapy
Document Type(s): Article,
Countries: Australia, UK,
Click here for the abstract
C:
Y:
Ophthalmology,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publication(s):  JHEOR 2017;5(1):89-108
Document Type(s): Article,
Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK,
C:
Y:
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017
  L:
A:
English
Epidemiological study, Public Health,
  Add to report
 
 
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS
Author(s): Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F*
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2017
Document Type(s): Poster,
Countries: Australia, Canada, France, UK,
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2017
  L:
A:
English
Cost effectiveness, Literature Review, Pricing & Reimbursement, Review,
  Add to report
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publication(s):  Clinical Epidemiology
Document Type(s): Article,
Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK,
Click here for the abstract
C:
Y:
Oncology,
2016
  L:
A:
English
Literature Review,
  Add to report
 
 
 1 of 5 Next Page Last Page